A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea

Verfasser / Beitragende:
[B. Genton, I. Betuela, I. Felger, F. Al-Yaman, R. F. Anders, A. Saul, L. Rare, M. Baisor, K. Lorry, G. V. Brown, D. Pye, D. O. Irving, T. A. Smith, H. P. Beck, M. P. Alpers]
Ort, Verlag, Jahr:
2002
Enthalten in:
Journal of Infectious Diseases, 185/6(2002-03), 820-7
Format:
Artikel (online)
ID: 439477336